Published in J Biol Chem on September 29, 2000
ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer (2010) 3.44
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev (2010) 3.27
Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev (2010) 2.97
Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch (2006) 1.58
Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther Deliv (2011) 1.57
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J (2003) 1.57
The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes. Genome Biol (2004) 1.55
The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res (2009) 1.46
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J (2011) 1.41
ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res (2005) 1.37
ABCC10, ABCC11, and ABCC12. Pflugers Arch (2006) 1.34
MRP subfamily transporters and resistance to anticancer agents. J Bioenerg Biomembr (2001) 1.24
Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci (2002) 1.22
Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem (2011) 1.15
Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP. Neuropsychopharmacology (2006) 1.15
Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer (2011) 1.08
Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway. Br J Pharmacol (2007) 1.08
Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J (2005) 1.04
Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. Antimicrob Agents Chemother (2004) 1.04
Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia (2010) 1.04
Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol Pharmacol (2007) 1.03
Multidrug resistance transporters in the olfactory receptor neurons of Xenopus laevis tadpoles. J Physiol (2003) 1.02
Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol (2008) 0.99
Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J (2002) 0.99
Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters. Annu Rev Pharmacol Toxicol (2012) 0.97
Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP. Mol Pharmacol (2011) 0.95
Emerging role for drug transporters at the blood-testis barrier. Trends Pharmacol Sci (2010) 0.95
Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo. Am J Cancer Res (2015) 0.94
Effluxing ABC transporters in human corneal epithelium. J Pharm Sci (2010) 0.93
Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos (2008) 0.93
ABCC5, a gene that influences the anterior chamber depth, is associated with primary angle closure glaucoma. PLoS Genet (2014) 0.92
Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5). Theor Biol Med Model (2007) 0.91
Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance. Mol Pharmacol (2009) 0.91
Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. Am J Pathol (2005) 0.90
ATP-binding cassette transporters in human heart failure. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.90
Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart. Am J Pathol (2003) 0.90
Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology (2008) 0.90
Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Nat Chem Biol (2014) 0.89
The genetic mechanisms of primary angle closure glaucoma. Eye (Lond) (2015) 0.88
Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. J Clin Invest (2014) 0.87
MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes. Eur J Pharmacol (2012) 0.87
New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies. J Exp Clin Cancer Res (2015) 0.87
Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochem Pharmacol (2005) 0.86
ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone. Breast Cancer Res (2012) 0.86
ATP-binding cassette (ABC) transporter expression and localization in sea urchin development. Dev Dyn (2012) 0.86
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure. Theor Biol Med Model (2009) 0.84
Roles of sildenafil in enhancing drug sensitivity in cancer. Cancer Res (2011) 0.83
Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression. BMC Mol Biol (2007) 0.83
Cellular and regional specific changes in multidrug efflux transporter expression during recovery of vasogenic edema in the rat hippocampus and piriform cortex. BMB Rep (2015) 0.82
N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc Natl Acad Sci U S A (2015) 0.80
New perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP efflux and extracellular cAMP-adenosine pathway. Front Pharmacol (2015) 0.80
Functional evidence of multidrug resistance transporters (MDR) in rodent olfactory epithelium. PLoS One (2012) 0.80
Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice. Blood (2015) 0.79
Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies. J Med Chem (2012) 0.79
Placental ABC Transporters: Biological Impact and Pharmaceutical Significance. Pharm Res (2016) 0.79
ABCC5 is required for cAMP-mediated hindgut invagination in sea urchin embryos. Development (2015) 0.78
FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models. Am J Transl Res (2015) 0.77
ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs. J Biol Chem (2015) 0.77
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics J (2015) 0.76
Differential expression of multidrug resistance protein 5 and phosphodiesterase 5 and regulation of cGMP levels in phasic and tonic smooth muscle. Am J Physiol Gastrointest Liver Physiol (2013) 0.76
ABCC5 transporter is a novel type 2 diabetes susceptibility gene in European and African American populations. Ann Hum Genet (2014) 0.75
Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants. Front Pharmacol (2013) 0.75
PDE2 is a novel target for attenuating tumor formation in a mouse model of UVB-induced skin carcinogenesis. PLoS One (2014) 0.75
Genetic variants associated with gastrointestinal symptoms in Fabry disease. Oncotarget (2016) 0.75
Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation. Oncotarget (2017) 0.75
Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration. Sci Rep (2016) 0.75
Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11. Antimicrob Agents Chemother (2017) 0.75
Gestational Zearalenone Exposure Causes Reproductive and Developmental Toxicity in Pregnant Rats and Female Offspring. Toxins (Basel) (2017) 0.75
Hypotonic cell swelling stimulates permeability to cAMP in a rat colonic cell line. Pflugers Arch (2004) 0.75
The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane. J Membr Biol (2003) 0.75
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet (1996) 3.77
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun (1986) 3.42
The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem (1994) 2.82
Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol (1974) 2.76
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55
Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol (1968) 2.47
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol (2000) 2.21
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem (2000) 2.06
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta (1999) 1.99
Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. Biochem J (1987) 1.97
Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem (2000) 1.85
Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol (1999) 1.84
The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology (1997) 1.83
ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res (1994) 1.73
DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension (1999) 1.71
Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res (1996) 1.69
cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem (1996) 1.66
Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology (1993) 1.58
A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system. Clin Chim Acta (1988) 1.53
The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol (1988) 1.49
ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J (1997) 1.44
Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin Pharmacol Ther (2013) 1.42
UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci (1990) 1.39
Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology (1996) 1.36
Studies on the purification of rat liver uridine diphosphate glucuronyltransferase. Biochem J (1977) 1.35
Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. Eur J Pharmacol (1993) 1.34
ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem (1990) 1.32
Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience (2004) 1.30
Enzymic determination of uracil nucleotides in tissues. Anal Biochem (1970) 1.30
ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J (1996) 1.29
Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR). Eur J Biochem (1996) 1.28
Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem (1999) 1.27
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer (2001) 1.23
Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology (2001) 1.22
Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem (1969) 1.22
Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology (1999) 1.20
Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol (1995) 1.20
Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology (1987) 1.19
Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells. Eur J Biochem (1994) 1.19
Development of phenobarbital-sensitive control mechanisms for uridine diphosphate glucuronyltransferase activity in chick embryo liver. J Cell Biol (1972) 1.18
ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem (1991) 1.18
Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology (2001) 1.18
Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest (1991) 1.17
Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol (1997) 1.17
Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci (1998) 1.16
Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci U S A (1988) 1.16
Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. Clin Chim Acta (1997) 1.14
Substrate specificity and properties of uridine diphosphate glucuronyltransferase purified to apparent homogeneity from phenobarbital-treated rat liver. Biochem J (1978) 1.14
Staphylococcal enterotoxin B as a nonimmunological mast cell stimulus in primates: the role of endogenous cysteinyl leukotrienes. Int Arch Allergy Appl Immunol (1987) 1.14
Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol (2001) 1.14
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J (1994) 1.12
Aluminum ions are required for stabilization and inhibition of hepatic microsomal glucose-6-phosphatase by sodium fluoride. J Biol Chem (1986) 1.12
Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol (1998) 1.11
Galactosamine induced liver injury. Prog Liver Dis (1972) 1.10
Development of multiple activities of UDP-glucuronyltransferase in human liver. Biochem J (1987) 1.09
The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J Neurochem (2001) 1.09
Stabilization of partially-purified glucose 6-phosphatase by fluoride. Is enzyme inactivation caused by dephosphorylation? FEBS Lett (1980) 1.09
Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem (1986) 1.07
Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology (1994) 1.06
Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics (1993) 1.06
Nucleotide and deduced amino acid sequence of human liver microsomal epoxide hydrolase. Nucleic Acids Res (1987) 1.06
Phospholipid content and activity of pure uridine diphosphate-glucuronyltransferase from rat liver. Biochem J (1978) 1.06
Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience (2005) 1.06
The relation of leukotrienes to liver injury. Hepatology (1985) 1.05
Stabilization of glucose-6-phosphatase activity by a 21 000-dalton hepatic microsomal protein. Biochem J (1985) 1.05
Leukotrienes as mediators in tissue trauma. Science (1985) 1.05
Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronyltransferase enzyme protein. FEBS Lett (1985) 1.04
Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family. Biochem J (1991) 1.04
Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats. Exp Mol Pathol (1970) 1.04
In vitro methods to support transporter evaluation in drug discovery and development. Clin Pharmacol Ther (2013) 1.04
Isolation and purification of bilirubin UDP-glucuronyl-transferase from rat liver. FEBS Lett (1980) 1.03
Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem (1993) 1.03
The full length coding sequence of rat liver androsterone UDP-glucuronyltransferase cDNA and comparison with other members of this gene family. Nucleic Acids Res (1986) 1.03
A simple method for purification of epoxide hydratase from rat liver. Biochem J (1977) 1.02
Purification of UDP-glucuronyltransferase from untreated rat liver. FEBS Lett (1977) 1.01
Production of peptide leukotrienes in endotoxin shock. FEBS Lett (1985) 1.01
Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett (1993) 1.01
Reactivation of a pure defective UDP-glucuronyltransferase from homozygous Gunn rat liver. FEBS Lett (1978) 1.00
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J Pharmacol Exp Ther (2002) 1.00
Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF-B. Hepatology (1998) 1.00
Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology (2000) 1.00
Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. Eur J Biochem (2000) 0.99
An investigation of the transverse topology of bilirubin UDP-glucuronosyltransferase in rat hepatic endoplasmic reticulum. Biochem J (1989) 0.99
Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology (1999) 0.99
New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease". Hepatology (1992) 0.99
Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. Ann Hum Genet (1990) 0.99
The substrate supply of the human skeletal muscle at rest, during and after work. Experientia (1967) 0.99
Characterization and quantification of rat bile phosphatidylcholine by electrospray-tandem mass spectrometry. Anal Biochem (1997) 0.99
Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J Clin Invest (1993) 0.98
Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell culture. FEBS Lett (1989) 0.97
Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol (1999) 0.97
4-Nitrophenol UDPglucuronyltransferase (rat liver). Methods Enzymol (1981) 0.97
The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochem Pharmacol (1993) 0.97
Leukotriene antagonists prevent endotoxin lethality. Naturwissenschaften (1982) 0.96
Defective induction of phenol glucuronidation by 3-methylcholanthrene in Gunn rats is due to the absence of a specific UDP-glucuronosyltransferase isoenzyme. Mol Pharmacol (1987) 0.96
Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. Hoppe Seylers Z Physiol Chem (1971) 0.96
Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J (1999) 0.96
Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos (1993) 0.96